메뉴 건너뛰기




Volumn 27, Issue 4, 2012, Pages 386-391

What is the prevalence of resistant hypertension in the United States?

Author keywords

National Health and Nutrition Examination Surveys; resistant hypertension

Indexed keywords

CHLORTALIDONE; DIURETIC AGENT; EPLERENONE; SPIRONOLACTONE; TRANDOLAPRIL PLUS VERAPAMIL; VERAPAMIL;

EID: 84862283966     PISSN: 02684705     EISSN: 15317080     Source Type: Journal    
DOI: 10.1097/HCO.0b013e328353ad6e     Document Type: Review
Times cited : (65)

References (30)
  • 1
    • 49249106417 scopus 로고    scopus 로고
    • Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American heart association professional education committee of the council for high blood pressure research
    • Calhoun DA, Jones D, Textor S, Goff DC, et al. Resistant hypertension: Diagnosis, evaluation, and treatment: A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Hypertension 2008; 51:1403-1419.
    • (2008) Hypertension , vol.51 , pp. 1403-1419
    • Calhoun, D.A.1    Jones, D.2    Textor, S.3    Goff, D.C.4
  • 2
    • 80054766288 scopus 로고    scopus 로고
    • Benefits from treatment and control of patients with resistant hypertension
    • Doumas M, Papademetriou V, Douma S, et al. Benefits from treatment and control of patients with resistant hypertension. Int J Hypertens 2010; 22:318549.
    • (2010) Int. J. Hypertens , vol.22 , pp. 318549
    • Doumas, M.1    Papademetriou, V.2    Douma, S.3
  • 4
    • 18844389740 scopus 로고    scopus 로고
    • Resistant hypertension revisited: A comparison of two university-based cohorts
    • Garg JP, Elliott WJ, Folker A, et al. Resistant hypertension revisited: A comparison of two university-based cohorts. Am J Hypertens 2005; 18: 619-626.
    • (2005) Am. J. Hypertens , vol.18 , pp. 619-626
    • Garg, J.P.1    Elliott, W.J.2    Folker, A.3
  • 5
    • 78650875954 scopus 로고    scopus 로고
    • Burden of resistant hypertension in hypertensive patients with nondialysis chronic kidney disease
    • De Nicola L, Borrelli S, Gabbai FB, et al. Burden of resistant hypertension in hypertensive patients with nondialysis chronic kidney disease. Kidney Blood Press Res 2011; 34:58-67.
    • (2011) Kidney Blood Press Res. , vol.34 , pp. 58-67
    • De Nicola, L.1    Borrelli, S.2    Gabbai, F.B.3
  • 6
    • 0026001631 scopus 로고
    • Resistant hypertension in a tertiary care clinic
    • Yakovlevitch M, Black HR. Resistant hypertension in a tertiary care clinic. Arch Intern Med 1991; 151:1786-1792.
    • (1991) Arch. Intern. Med. , vol.151 , pp. 1786-1792
    • Yakovlevitch, M.1    Black, H.R.2
  • 7
    • 84855343254 scopus 로고    scopus 로고
    • Refractory hypertension: Definition, prevalence, and patient characteristics
    • Acelajado MC, Pisoni R, Dudenbostel T, et al. Refractory hypertension: Definition, prevalence, and patient characteristics. J Clin Hypertens (Greenwich) 2012; 14:7-12.
    • (2012) J. Clin. Hypertens (Greenwich) , Issue.14 , pp. 7-12
    • Acelajado, M.C.1    Pisoni, R.2    Dudenbostel, T.3
  • 8
    • 0036863587 scopus 로고    scopus 로고
    • Success and predictors of blood pressure control in diverse North American settings: The antihypertensive and lipid-lowering treatment to prevent heart attack trial (allhAT)
    • Cushman WC, Ford CE, Cutler JA, et al. Success and predictors of blood pressure control in diverse North American settings: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens 2002; 4:393-404.
    • (2002) J. Clin. Hypertens , vol.4 , pp. 393-404
    • Cushman, W.C.1    Ford, C.E.2    Cutler, J.A.3
  • 9
    • 0345492460 scopus 로고    scopus 로고
    • A calcium antagonist vs a noncalcium antagonist hypertension treatment strategy for patients with coronary artery disease
    • The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial
    • Pepine CJ, Handberg EM, Cooper-DeHoff RM, et al. A calcium antagonist vs. a noncalcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): A randomized controlled trial. JAMA 2003; 290:2805-2816.
    • (2003) JAMA , vol.290 , pp. 2805-2816
    • Pepine, C.J.1    Handberg, E.M.2    Cooper-DeHoff, R.M.3
  • 10
    • 84855982670 scopus 로고    scopus 로고
    • Baseline predictors of resistant hypertension in the anglo-scandinavian cardiac outcome trial (ascot): A risk score to identify those at high-risk
    • for the ASCOT investigators
    • Gupta AK, Nasothimiou EG, Chang CL, et al. for the ASCOT investigators. Baseline predictors of resistant hypertension in the Anglo-Scandinavian Cardiac Outcome Trial (ASCOT): A risk score to identify those at high-risk. J Hypertens 2011; 29:2004-2013.
    • (2011) J. Hypertens , vol.29 , pp. 2004-2013
    • Gupta, A.K.1    Nasothimiou, E.G.2    Chang, C.L.3
  • 11
    • 0037851836 scopus 로고    scopus 로고
    • Principal results of the controlled onset verapamil investigation of cardiovascular end points (convinCE) trial
    • for the CONVINCE Research Group
    • Black HR, Elliott WJ, Grandits G, et al. for the CONVINCE Research Group. Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial. JAMA 2003; 289:2073-2082.
    • (2003) JAMA , vol.289 , pp. 2073-2082
    • Black, H.R.1    Elliott, W.J.2    Grandits, G.3
  • 12
    • 57349138291 scopus 로고    scopus 로고
    • Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
    • for the ACCOMPLISH Trial Investigators
    • Jamerson K, Weber MA, Bakris GL, et al. for the ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 2008; 359:2417-2428.
    • (2008) N. Engl. J. Med. , vol.359 , pp. 2417-2428
    • Jamerson, K.1    Weber, M.A.2    Bakris, G.L.3
  • 13
    • 84859424203 scopus 로고    scopus 로고
    • Incidence and prognosis of resistant hypertension in hypertensive patients
    • Epub ahead of print]
    • Daugherty SL, Powers JD, Magid DJ, et al. Incidence and prognosis of resistant hypertension in hypertensive patients. Circulation 2012. [Epub ahead of print]
    • (2012) Circulation
    • Daugherty, S.L.1    Powers, J.D.2    Magid, D.J.3
  • 14
    • 83155175106 scopus 로고    scopus 로고
    • Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents
    • Hanselin MR, Saseen JJ, Allen RR, et al. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension 2011; 58:1008-1013.
    • (2011) Hypertension , vol.58 , pp. 1008-1013
    • Hanselin, M.R.1    Saseen, J.J.2    Allen, R.R.3
  • 15
    • 77949606480 scopus 로고    scopus 로고
    • Treatment resistant hypertension in a community-based practice network [abstract
    • Egan BM, Zhao Y, Rehman SU, et al. Treatment resistant hypertension in a community-based practice network [abstract]. J Clin Hypertens (Greenwich) 2009; 11:A6.
    • (2009) J. Clin. Hypertens (Greenwich) , vol.11
    • Egan, B.M.1    Zhao, Y.2    Rehman, S.U.3
  • 16
    • 66949115332 scopus 로고    scopus 로고
    • Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting
    • McAdam-Marx C, Ye X, Sung JC, et al. Results of a retrospective, observational pilot study using electronic medical records to assess the prevalence and characteristics of patients with resistant hypertension in an ambulatory care setting. Clin Ther 2009; 31:1116-1123.
    • (2009) Clin. Ther. , vol.31 , pp. 1116-1123
    • McAdam-Marx, C.1    Ye, X.2    Sung, J.C.3
  • 17
    • 51249098299 scopus 로고    scopus 로고
    • Association between refractory hypertension and cardiometabolic risk factors: The hiperfre study (in Spanish)
    • Otero FR, Grigorian LS, Lado ML, et al. Association between refractory hypertension and cardiometabolic risk factors: The HIPERFRE study (in Spanish). Nefrologia 2008; 28:425-432.
    • (2008) Nefrologia , vol.28 , pp. 425-432
    • Otero, F.R.1    Grigorian, L.S.2    Lado, M.L.3
  • 18
    • 79955481070 scopus 로고    scopus 로고
    • Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring
    • De la Sierra A, Segura J, Banegas JE, et al. Clinical features of 8295 patients with resistant hypertension classified on the basis of ambulatory blood pressure monitoring. Hypertension 2011; 57:898-902.
    • (2011) Hypertension , vol.57 , pp. 898-902
    • De La Sierra, A.1    Segura, J.2    Banegas, J.E.3
  • 19
    • 84869498992 scopus 로고    scopus 로고
    • Home vs. ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension
    • doi 10:1038/jhh. 2011.98. [Epub ahead of print]
    • Nasothimiou EG, Tzamouranis D, Roussias LG, Stergious GS. Home vs. ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension. J Hum Hypertens 2011; doi 10:1038/jhh. 2011.98. [Epub ahead of print]
    • (2011) J. Hum Hypertens
    • Nasothimiou, E.G.1    Tzamouranis, D.2    Roussias, L.G.3    Stergious, G.S.4
  • 20
    • 85027963477 scopus 로고    scopus 로고
    • Prevalence of resistant hypertension in the United States
    • Persell S. Prevalence of resistant hypertension in the United States. Hypertension 2011; 57:1076-1080.
    • (2011) Hypertension , vol.57 , pp. 1076-1080
    • Persell, S.1
  • 21
    • 0347423198 scopus 로고    scopus 로고
    • Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure
    • Chobanian AV, Bakris GL, Black HR, et al. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
    • (2003) Hypertension , vol.42 , pp. 1206-1252
    • Chobanian, A.V.1    Bakris, G.L.2    Black, H.R.3
  • 22
    • 34249655660 scopus 로고    scopus 로고
    • Treatment of hypertension in the prevention and management of ischemic heart disease
    • A Scientific Statement from the American Heart Association Council for High Blood Pressure Research, and the Councils on Clinical Cardiology and Epidemiology and Prevention
    • Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease. A Scientific Statement from the American Heart Association Council for High Blood Pressure Research, and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation 2007; 115:2761-2788.
    • (2007) Circulation , vol.115 , pp. 2761-2788
    • Rosendorff, C.1    Black, H.R.2    Cannon, C.P.3
  • 23
    • 77952750659 scopus 로고    scopus 로고
    • US trends in prevalence awareness treatment and control of hypertension 1998-2008
    • Egan BM, Zhao Y, Axon RN. US trends in prevalence, awareness, treatment and control of hypertension: 1998-2008. JAMA 2010; 303:2043-2050.
    • (2010) JAMA , vol.303 , pp. 2043-2050
    • Egan, B.M.1    Zhao, Y.2    Axon, R.N.3
  • 24
    • 80052293937 scopus 로고    scopus 로고
    • Uncontrolled and apparent treatment resistant hypertension in the United States, 1988- 2008
    • Egan B, Zhao Y, Axon R, Brzezinski W, et al. Uncontrolled and apparent treatment resistant hypertension in the United States, 1988-2008. Circulation 2011; 124:1046-1058.
    • (2011) Circulation , Issue.124 , pp. 1046-1058
    • Egan, B.1    Zhao, Y.2    Axon, R.3    Brzezinski, W.4
  • 25
    • 84871511126 scopus 로고    scopus 로고
    • Deaths: Preliminary data for 2010
    • Available on the internet at [accessed 6 March 2012]
    • Murphy SL, Xu J, Kochanek KD. Deaths: Preliminary data for 2010. Nat Vital Stat Rep 2012; 60:1-69; Available on the internet at: Http://www.cdc.gov/ nchs/data/nvsr/nvsr60/nvsr60-04.pdf. [accessed 6 March 2012].
    • (2012) Nat. Vital. Stat. Rep. , vol.60 , pp. 1-69
    • Murphy, S.L.1    Xu, J.2    Kochanek, K.D.3
  • 26
    • 84856487711 scopus 로고    scopus 로고
    • Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999- 2010
    • Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307:491-497.
    • (2012) JAMA , Issue.307 , pp. 491-497
    • Flegal, K.M.1    Carroll, M.D.2    Kit, B.K.3    Ogden, C.L.4
  • 27
    • 34047197931 scopus 로고    scopus 로고
    • For the anglo-scandinavian cardiac outcomes trial investigators Effect of spironolactone on blood pressure in subjects with resistant hypertension
    • Chapman N, Dobson J, Wilson S, et al. For the Anglo-Scandinavian Cardiac Outcomes Trial Investigators. Effect of spironolactone on blood pressure in subjects with resistant hypertension. Hypertension 2007; 49:839-845.
    • (2007) Hypertension , vol.49 , pp. 839-845
    • Chapman, N.1    Dobson, J.2    Wilson, S.3
  • 28
    • 79954692757 scopus 로고    scopus 로고
    • A double-blind randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism
    • Parthasarathy HK, Mé nard J, White WB, et al. A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism. J Hypertens 2011; 29:980-990.
    • (2011) J. Hypertens , vol.29 , pp. 980-990
    • Parthasarathy, H.K.1    Ménard, J.2    White, W.B.3
  • 29
    • 84864193654 scopus 로고    scopus 로고
    • For The Guideline Development Groups, National Colllaborating Centres, and NICE Project Team. United Kingdom National Health Service: National Institute for Health and Clinical Excellence. NICE clinical guideline 127: Hypertension [accessed 24 August
    • Williams B, Williams H, Northedge J, et al., For The Guideline Development Groups, National Colllaborating Centres, and NICE Project Team. United Kingdom National Health Service: National Institute for Health and Clinical Excellence. NICE clinical guideline 127: Hypertension: Clinical management of primary hypertension in adults. http://www.nice.org.uk/CG127. [accessed 24 August 2011]
    • (2011) Clinical Management of Primary Hypertension in Adults
    • Williams, B.1    Williams, H.2    Northedge, J.3
  • 30
    • 84862280354 scopus 로고    scopus 로고
    • Hypertension specialists' current and potential impact on resistant hypertension in the Medicare population [abstract]
    • Elliott WJ, Egan BM, Giles TD, et al. Hypertension specialists' current and potential impact on resistant hypertension in the Medicare population [abstract]. J Clin Hypertens (Greenwich) 2011; 13 (Suppl. 1):A153.
    • (2011) J. Clin. Hypertens (Greenwich) , vol.13 , Issue.SUPPL. 1
    • Elliott, W.J.1    Egan, B.M.2    Giles, T.D.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.